Trelagliptin
Trelagliptin-4002
Approved small_molecule completed
Quick answer
Trelagliptin for Type 2 Diabetes is a Approved program (small_molecule) at Takeda with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Takeda
- Indication
- Type 2 Diabetes
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed